These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 27690687)

  • 1. A comparison between the effects of metformin and megestrol on simple endometrial hyperplasia.
    Sharifzadeh F; Aminimoghaddam S; Kashanian M; Fazaeli M; Sheikhansari N
    Gynecol Endocrinol; 2017 Feb; 33(2):152-155. PubMed ID: 27690687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin plus megestrol acetate compared with megestrol acetate alone as fertility-sparing treatment in patients with atypical endometrial hyperplasia and well-differentiated endometrial cancer: a randomised controlled trial.
    Yang BY; Gulinazi Y; Du Y; Ning CC; Cheng YL; Shan WW; Luo XZ; Zhang HW; Zhu Q; Ma FH; Liu J; Sun L; Yu M; Guan J; Chen XJ
    BJOG; 2020 Jun; 127(7):848-857. PubMed ID: 31961463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of adjunctive metformin to progesterone for the treatment of non-atypical endometrial hyperplasia in a randomized fashion, a placebo-controlled, double blind clinical trial.
    Tehranian A; Ghahghaei-Nezamabadi A; Arab M; Khalagi K; Aghajani R; Sadeghi S
    J Gynecol Obstet Hum Reprod; 2021 Jun; 50(6):101863. PubMed ID: 32652300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing the Administration of Letrozole and Megestrol Acetate in the Treatment of Women with Simple Endometrial Hyperplasia without Atypia: A Randomized Clinical Trial.
    Moradan S; Nikkhah N; Mirmohammadkhanai M
    Adv Ther; 2017 May; 34(5):1211-1220. PubMed ID: 28353144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiproliferative effect of metformin on the endometrium--a clinical trial.
    Tabrizi AD; Melli MS; Foroughi M; Ghojazadeh M; Bidadi S
    Asian Pac J Cancer Prev; 2014; 15(23):10067-70. PubMed ID: 25556427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Randomized Clinical Trial of Levonorgestrel Intrauterine System with or without Metformin for Treatment of Endometrial Hyperplasia without Atypia in Indian Women.
    Ravi RD; Kalra J; Srinivasan R; Bagga R; Jain V; Suri V; Sachdeva N
    Asian Pac J Cancer Prev; 2021 Mar; 22(3):983-989. PubMed ID: 33773565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conservative therapy with metformin plus megestrol acetate for endometrial atypical hyperplasia.
    Shan W; Wang C; Zhang Z; Gu C; Ning C; Luo X; Zhou Q; Chen X
    J Gynecol Oncol; 2014 Jul; 25(3):214-20. PubMed ID: 25045434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reverse of progestin-resistant atypical endometrial hyperplasia by metformin and oral contraceptives.
    Shen ZQ; Zhu HT; Lin JF
    Obstet Gynecol; 2008 Aug; 112(2 Pt 2):465-7. PubMed ID: 18669766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effect of megestrol acetate in the treatment of endometrial hyperplasia.
    Gal D; Edman CD; Vellios F; Forney JP
    Am J Obstet Gynecol; 1983 Jun; 146(3):316-22. PubMed ID: 6859142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conservative treatment for atypical endometrial hyperplasia: what is the most effective therapeutic method?
    Kim MK; Seong SJ
    J Gynecol Oncol; 2014 Jul; 25(3):164-5. PubMed ID: 25045426
    [No Abstract]   [Full Text] [Related]  

  • 11. Abnormal vaginal bleeding following pharmacist prescribing of metformin leads to the detection of complex endometrial hyperplasia.
    Lyster RL; Houle SK
    Ann Pharmacother; 2013 Nov; 47(11):1581-3. PubMed ID: 24285770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of antiproliferative effects of metformine and progesterone on estrogen-induced endometrial hyperplasia in rats.
    Tas M; Kutuk MS; Serin IS; Ozgun MT; Oner G; Ozturk F
    Gynecol Endocrinol; 2013 Apr; 29(4):311-4. PubMed ID: 23305503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin for endometrial hyperplasia: a Cochrane protocol.
    Clement NS; Oliver TR; Shiwani H; Saner JR; Mulvaney CA; Atiomo W
    BMJ Open; 2016 Aug; 6(8):e013385. PubMed ID: 27531741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing letrozole with medroxyprogesterone acetate (MPA) as hormonal therapy for simple endometrial hyperplasia without atypia in adult and middle-aged women.
    Tabatabaie A; Karimi Zarchi M; Dehghani-Tafti M; Miratashi-Yazdi A; Teimoori S; Dehghani A
    Eur J Gynaecol Oncol; 2013; 34(6):552-5. PubMed ID: 24601050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells.
    Xie Y; Wang YL; Yu L; Hu Q; Ji L; Zhang Y; Liao QP
    J Steroid Biochem Mol Biol; 2011 Sep; 126(3-5):113-20. PubMed ID: 21168492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
    Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of atypical endometrial hyperplasia with an insulin-sensitizing agent.
    Session DR; Kalli KR; Tummon IS; Damario MA; Dumesic DA
    Gynecol Endocrinol; 2003 Oct; 17(5):405-7. PubMed ID: 14710588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pregnant rate and pregnancy-relating factors of patients with early endometrial carcinoma and severe atypical hyperplasia of endometrium after fertility-preserving treatment by progestin].
    Cao DY; Yu M; Yang JX; Shen K; Huang HF; Cheng NH; Sun ZY; Deng CY; Yu Q; He FF
    Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):519-22. PubMed ID: 24284224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperglycemia secondary to megestrol acetate for endometrial neoplasia.
    Rose PG
    Gynecol Oncol; 1996 Apr; 61(1):139-41. PubMed ID: 8626102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncologic and reproductive outcomes after fertility-sparing management with oral progestin for women with complex endometrial hyperplasia and endometrial cancer.
    Chen M; Jin Y; Li Y; Bi Y; Shan Y; Pan L
    Int J Gynaecol Obstet; 2016 Jan; 132(1):34-8. PubMed ID: 26493012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.